CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer
Authors
A Calles
A Santoro
+40 more
Beth Overmoyer
C Basilico
Cloud Paweletz
CM Perou
CR Graveel
E Lengyel
Elena Ivanova
Eliezer Van Allen
EM Allen Van
Eric P. Winer
Geoffrey I. Shapiro
GV Scagliotti
H Kuniyasu
Hao Guo
Ian E. Krop
IL Andrulis
J Yamashita
Jane Brock
John J. Wright
JY Kang
K Cibulskis
Katherine Larrabee
L Boix
L Goyal
LS Rosen
LV Sequist
MG Ponzo
Nikhil Wagle
P Eroles
P Michieli
Pasi Janne
R Katayama
R Siegel
RA McClelland
RL Camp
Sally Tan
Sara M. Tolaney
SM Sheen-Chen
TA Yap
William Barry
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs10637-015-...
Last time updated on 15/03/2019